These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16519246)

  • 1. Protease inhibitors: the current status.
    Dauer B
    J HIV Ther; 2005 Dec; 10(4):72-4. PubMed ID: 16519246
    [No Abstract]   [Full Text] [Related]  

  • 2. New protease inhibitors and non-nucleoside reverse transcriptase inhibitors.
    Lascar M; Cartledge JD
    J HIV Ther; 2008 Jun; 13(2):40-4. PubMed ID: 18953273
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of tipranavir versus darunavir in treatment-experienced patients enrolling.
    AIDS Patient Care STDS; 2007 Aug; 21(8):6-3. PubMed ID: 17902242
    [No Abstract]   [Full Text] [Related]  

  • 4. A lame duck, a dark horse, and a goat.
    Huff B
    GMHC Treat Issues; 2005; 19(5-6):4-5. PubMed ID: 16193576
    [No Abstract]   [Full Text] [Related]  

  • 5. Relative antiviral efficacy should not be inferred from cross-trial comparisons.
    Hall D
    HIV Med; 2007 Nov; 8(8):570-1; author reply 571-2. PubMed ID: 17944692
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV protease inhibitors: recent clinical trials and recommendations on use.
    Fernández-Montero JV; Barreiro P; Soriano V
    Expert Opin Pharmacother; 2009 Jul; 10(10):1615-29. PubMed ID: 19527188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reviving protease inhibitors: new data and more options.
    Murphy RL
    J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 1():S43-52; quiz S53, S55-6. PubMed ID: 12946064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perspectives: hope for therapy experienced patients. Tipranavir shows superior effectiveness with comparable safety].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():44-5. PubMed ID: 16385873
    [No Abstract]   [Full Text] [Related]  

  • 9. European Commission grants full approval for Aptivus.
    AIDS Patient Care STDS; 2008 May; 22(5):438. PubMed ID: 18521974
    [No Abstract]   [Full Text] [Related]  

  • 10. Darunavir in the treatment of HIV-1 infection: a viewpoint by Mark Holodniy.
    Holodniy M
    Drugs; 2007; 67(18):2803. PubMed ID: 18062725
    [No Abstract]   [Full Text] [Related]  

  • 11. [Position of darunavir in antiretroviral therapy].
    Clotet B
    Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 10():61-2. PubMed ID: 19195461
    [No Abstract]   [Full Text] [Related]  

  • 12. Tipranavir.
    Gallant J
    Drugs; 2003; 63(15):1619-20. PubMed ID: 12887269
    [No Abstract]   [Full Text] [Related]  

  • 13. Salvage therapy update.
    Emery C
    Surviv News (Atlanta Ga); 2005; 16(6):8. PubMed ID: 16388538
    [No Abstract]   [Full Text] [Related]  

  • 14. Some existing drugs work on resistant HIV.
    AIDS Alert; 2000 Jan; 15(1):10-2. PubMed ID: 11366357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Darunavir.
    El-Atrouni WI; Temesgen Z
    Drugs Today (Barc); 2007 Oct; 43(10):671-9. PubMed ID: 17987220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darunavir in the treatment of HIV-1 infection: a viewpoint by Renslow Sherer.
    Sherer R
    Drugs; 2007; 67(18):2802-3. PubMed ID: 18062726
    [No Abstract]   [Full Text] [Related]  

  • 17. When and how to use tipranavir and darunavir.
    Hoffman CJ; Gallant JE
    AIDS Read; 2007 Apr; 17(4):194-8, 201. PubMed ID: 17479503
    [No Abstract]   [Full Text] [Related]  

  • 18. Tipranavir in the protease inhibitors arena.
    Vergani B; Rusconi S
    Drugs R D; 2011 Dec; 11(4):291-3. PubMed ID: 22133386
    [No Abstract]   [Full Text] [Related]  

  • 19. Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.
    de Requena DG; Bonora S; Calcagno A; D'Avolio A; Siccardi M; Fontana S; Milia MG; Sciandra M; Garazzino S; Di Garbo A; Baietto L; Trentini L; Di Perri G
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1066-71. PubMed ID: 18160524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tipranavir.
    Flexner C; Bate G; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Dec; 4(12):955-6. PubMed ID: 16370086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.